Thermo Fisher (TMO) Jumps 8.7% on Strong Q2 Earnings, Price Target Hikes
Thermo Fisher Scientific (TMO) shares jumped 8.71% on Thursday to close at $572.32, driven by strong Q2 earnings and a series of price target upgrades. Net income grew 7% year-over-year.
Key Numbers
Shares of Thermo Fisher Scientific Inc. (NYSE:TMO) rose 8.71% on Thursday to close at $572.32, as investors cheered the company's strong second-quarter earnings and subsequent price target upgrades from analysts.
Key Financial Results
| Metric | Value | YoY Change |
|---|---|---|
| Net Income | Not disclosed | +7% |
| Revenue | Not disclosed | — |
| EPS | Not disclosed | — |
Highlights from the Report
The company reported a 7% increase in net income compared to the same quarter last year, beating analyst expectations. Management cited improved demand across its life sciences and diagnostics segments.
Guidance
No official guidance was provided for the upcoming quarter.
Impact on the Stock
The stock surged 8.71% in a single session, marking its largest daily gain in months. Several analysts raised their price targets following the earnings release.
What This Means for Investors
The strong results reaffirm Thermo Fisher's leadership in the healthcare and biotech sector. However, investors should monitor future guidance and any shifts in demand for the company's products.
Frequently Asked Questions
Found this useful? Share it